Intervention Review

Antifibrinolytics for heavy menstrual bleeding

  1. Anne Lethaby1,*,
  2. Cindy Farquhar2,
  3. Inez Cooke3

Editorial Group: Cochrane Menstrual Disorders and Subfertility Group

Published Online: 23 OCT 2000

Assessed as up-to-date: 5 APR 2004

DOI: 10.1002/14651858.CD000249


How to Cite

Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD000249. DOI: 10.1002/14651858.CD000249.

Author Information

  1. 1

    School of Population Health,University of Auckland, Section of Epidemiology & Biostatistics, Auckland, New Zealand

  2. 2

    University of Auckland, Obstetrics and Gynaecology, Auckland, New Zealand

  3. 3

    Queen's University Belfast Institute of Clinical Science, School of Medicine, Obstetrics and Gynaecology, Belfast, Ireland

*Anne Lethaby, Section of Epidemiology & Biostatistics, School of Population Health,University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. a.lethaby@auckland.ac.nz.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 OCT 2000

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.